To include your compound in the COVID-19 Resource Center, submit it here.

Drug development costs unsustainable, Gottlieb warns

FDA Commissioner Scott Gottlieb Monday warned that the increasing cost of drug development is unsustainable and outlined steps FDA will take to reduce the cost and uncertainty associated with creating new drugs. If FDA reduces the cost and uncertainty of drug development, manufacturers should share some of the savings in the form of lower prices, he said.

“We're on an

Read the full 605 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers